Marine derived pharmaceuticals are drugs and other pharmacological substances which are made from extracting elements present in marine organisms. Marine organisms are particularly attractive because they conform to traditional drug "models" of natural product drug sources. In addition, supply of bulk amounts of a microbially-derived drugs can be addressed by large-scale fermentation of bioactive marine microorganisms.
This report contains market size and forecasts of Marine-derived Pharmaceuticals in Global, including the following market information:
Global Marine-derived Pharmaceuticals Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Marine-derived Pharmaceuticals market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Phenols Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Marine-derived Pharmaceuticals include Eli Lilly, Abbott, Bayer, Novartis, GlaxoSmithKline, PharmaMar and Sealife Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Marine-derived Pharmaceuticals companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Marine-derived Pharmaceuticals Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Marine-derived Pharmaceuticals Market Segment Percentages, by Type, 2021 (%)
Phenols
Steroids
Ethers
Peptides
Other
Global Marine-derived Pharmaceuticals Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Marine-derived Pharmaceuticals Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Marine-derived Pharmaceuticals Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Marine-derived Pharmaceuticals Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Marine-derived Pharmaceuticals revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Marine-derived Pharmaceuticals revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eli Lilly
Abbott
Bayer
Novartis
GlaxoSmithKline
PharmaMar
Sealife Pharma